Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - United States
Summary - Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (Thrive)
Deadline - Dec 19, 2025
GT reference number - 119905411
Product classification - Pharmaceutical products
Address - United States
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 119905411
Document Type - Tender Notices
Description - Description: Amendment 1: Added the Frequently Asked Questions (FAQ) to the list of attachments. The Advanced Research Projects Agency for Health (ARPA-H) Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program env isions a future where patients can opt for one-time therapeutic interventions designed to slow, reverse, or cure disease, harnessing revolutionary technologies and a rapidly evolving understanding of the genetic underpinnings of the biological processes that lead to disease. Interested parties are invited to review the attached THRIVE Innovative Solutions Opening (ISO) ARPA-H -SOL-25-122. For detailed information regarding Proposers' Day review S
Gt Ref Id - 119905411
Deadline - Dec 19, 2025
Similar Tenders :
|
Summary:
|
|
Summary:
|
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
